Ligand Pharma (LGND) Tops Q4 EPS by 52c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Ligand Pharma (LGND) Tops Q4 EPS by 52c

Ligand Reports Fourth Quarter and Full Year 2018 Financial Results

February 7, 2019 4:01 PM EST

Conference Call Begins at 4:30 p.m. Eastern Time Today

Analyst day to be held on Tuesday March 12 at 10:00 a.m. Eastern Time in New York City

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions.

The fourth quarter of 2018 capped off a year of superior... More